Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity - PubMed (original) (raw)

. 2020 Oct;93(4):508-511.

doi: 10.1111/cen.14276. Epub 2020 Aug 6.

Su Ann Tee 1, Yasir Ihsan 1, Waseem Athar 2, Gabriella Marchitelli 3, Donna Kelly 4, Christopher S Boot 5, Nadia Stock 3, James Macfarlane 2, Adrian R Martineau 6, Graham Burns 2, Richard Quinton 1 7

Affiliations

Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity

Grigorios Panagiotou et al. Clin Endocrinol (Oxf). 2020 Oct.

No abstract available

PubMed Disclaimer

Conflict of interest statement

Nothing to declare.

Comment in

Similar articles

Cited by

References

    1. Khunti K, Singh AK, Pareek M, Hanif W. Is ethnicity linked to incidence or outcomes of COVID‐19? BMJ. 2020;369:M1548. - PubMed
    1. Hill TR, Granic A, Davies K, et al. Serum 25‐hydroxyvitamin d concentration and its determinants in the very old: the newcastle 85+ study. Osteoporos Int. 2016;27(3):1199‐1208. - PubMed
    1. Pereira‐Santos M, Costa PR, Assis AM, Santos CA, Santos DB. obesity and vitamin d deficiency: a systematic review and meta‐analysis. Obes Rev. 2015;16(4):341‐349. - PubMed
    1. Gruber–Bzura BM. Vitamin D and influenza—prevention or therapy? Int J Mol Sci. 2018;19(8):2419. - PMC - PubMed
    1. Berry DJ, Hesketh K, Power C, Hypponen E. Vitamin D status has a linear association with seasonal infections and lung function in British adults. Br J Nutr. 2011;106(9):1433‐1440. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources